Sarepta Therapeutics     Print Page  Close Window

Events & Presentations

February 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. Please select a highlighted date from the calendar to see date-specific company information, including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-3-2-11234
567891011
1213
02/13/17
SC 13G/A
Formats:  Excel HTML Adobe PDF Word
14
02/14/17
SC 13G/A
Formats:  Excel HTML Adobe PDF Word
SC 13G/A
Formats:  Excel HTML Adobe PDF Word
SC 13G/A
Formats:  HTML Adobe PDF Word
15161718
1920212223
02/23/17
SC 13G
Formats:  Excel HTML Adobe PDF Word
2425
26272851525354
Calendar Instructions
Please select a highlighted date from the calendar to view company related information. This calendar requires JavaScript to be installed and activated on your browser.

UPCOMING EVENTS AND PRESENTATIONS

DateTitleAdd to Calendar HelpRemind MePrior to Event
02/28/17 4:30 p.m. ETQ4 2016 Sarepta Therapeutics Inc. Earnings Conference CallAdd Q4 2016 Sarepta Therapeutics Inc. Earnings Conference Call to Calendar days
Enter your e-mail address 

ARCHIVED EVENTS AND PRESENTATIONS

DateTitle 
01/10/17
7:30 a.m. PT
Sarepta Therapeutics Inc. at the JP Morgan Healthcare Conference
Download Event Supporting Material 
11/07/16
5:30 p.m. ET
Sarepta Therapeutics Inc. at the Credit Suisse 25th Annual Healthcare Conference
10/27/16
8:00 a.m. ET
Q3 2016 Sarepta Therapeutics Inc. Earnings Conference Call
09/19/16
4:00 p.m. ET
Sarepta Corporate Update on Accelerated Approval of EXONDYS 51TM Conference Call
 

This section of our website may contain dated or archived information which should not be considered current and may no longer be accurate. For current information, you are encouraged to review our most recent official corporate documents on file with the U.S. Securities and Exchange Commission.

Sarepta's recorded events and presentations contain forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by the FDA and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the company's Securities and Exchange Commission filings. Sarepta undertakes no obligation to revise or update the progress of these milestones except to the extent required under applicable federal and state securities laws.